Fulgent Genetics (FLGT) EV to CFO (2016 - 2026)

Fulgent Genetics has disclosed EV to CFO across 11 years of filings, most recently posting 12.71 for Q2 2026.

• In Q2 2026, EV to CFO fell 23.45% year-over-year to 12.71; the TTM figure through Jun 2026 stood at 3.61 (up 70.86% YoY), while the FY2025 annual figure was 4.67, down 132.02% from the prior year.
• EV to CFO came in at 12.71 for Q2 2026 at Fulgent Genetics, down from 24.91 in the prior quarter.
• In the past five years, EV to CFO ranged from a high of 102.55 in Q2 2022 to a low of 54.0 in Q1 2023.
• Average EV to CFO over 5 years is 16.57, with a median of 18.6 recorded in 2026.
• Year-over-year, EV to CFO surged 232.67% in 2022 and slumped 874.03% in 2023.
• Over 5 years, EV to CFO stood at 10.65 in 2022, then soared by 170.59% to 28.82 in 2023, then plunged by 57.35% to 12.29 in 2024, then plunged by 149.48% to 6.08 in 2025, then slumped by 109.01% to 12.71 in 2026.
• Per Business Quant data, the three most recent EV to CFO figures were 12.71 in Q2 2026, 24.91 in Q1 2026, and 6.08 in Q4 2025.